Vitamins C and E Tied to Lower Risk for Parkinson’s Disease

Vitamins C and E Tied to Lower Risk for Parkinson’s Disease

People who consume a diet rich in vitamins C and E may be at reduced risk for Parkinson’s disease.Researchers followed 41,058 Swedish men and women for an average of 18 years, gathering data on their health and diet. They assessed

Read More Vitamins C and E Tied to Lower Risk for Parkinson’s Disease

‘World first’ Parkinson’s treatment undergoing clinical trial in Toronto – National

‘World first’ Parkinson’s treatment undergoing clinical trial in Toronto - National

Researchers in Toronto are in the early stages of developing what’s being called a “world-first” treatment for Parkinson’s disease.Currently in its first phase of clinical trials, the ultimate goal of the new treatment would be to treat symptoms of

Read More ‘World first’ Parkinson’s treatment undergoing clinical trial in Toronto – National

Can a Parkinson’s Drug Treat Macular Degeneration?

Can a Parkinson's Drug Treat Macular Degeneration?

By Serena McNiff HealthDay Reporter WEDNESDAY, Sept. 16, 2020 (HealthDay News) — A drug long used to treat Parkinson’s disease may benefit patients with a severe form of age-related macular degeneration (AMD), a small clinical trial suggests. One

Read More Can a Parkinson’s Drug Treat Macular Degeneration?

Mitul Mehta: Brain scanners can help revolutionise psychiatric drugs

Mitul Mehta: Brain scanners can help revolutionise psychiatric drugs

Pushing the boundaries of conventional drug discovery methods, Mitul Mehta, who is a professor of neuroimaging and psychopharmacology at King’s College London, is using brain scanners to explore how psychedelic drugs and even hypnosis influence the brain in an effort

Read More Mitul Mehta: Brain scanners can help revolutionise psychiatric drugs